Tuesday, July 21, 2026

Intelligence · INN directory

Drugs Starting With R Intelligence

Browse 157 pharmaceutical drugs starting with "R" — INN profiles with FDA/EMA status, pipeline links, and patents.

Drugs in segment 157
Companies 800
Pipeline programs 335

Quick answer

NovaPharmaNews lists 157 pharmaceutical drugs whose INN (International Nonproprietary Name) begins with "R". Each profile includes regulatory status, brand names, originator companies, and cross-links to clinical pipeline and patent records.

157 drugs · Letter R · by data quality · Page 7 of 7

  1. recombinant coronavirus (sars-cov-2) vaccine

    COVGOZE

    PMDA: approved

  2. regorafenib hydrate

    STIVARGA INITIAL APPROVAL

    PMDA: approved

  3. resorcinol

    NULL

    TGA: approved

  4. respiratory syncytial virus rna vaccine

    MRESVIA

    PMDA: approved

  5. ritlecitinib tosilate

    LITFULO

    PMDA: approved

  6. refametinib

    NMPA: clinical trials

  7. remifentanil

    NMPA: clinical trials

  8. rezvilutamide

    NMPA: clinical trials

  9. rhgm-csf

    NMPA: clinical trials

  10. rivoceranib

    NMPA: clinical trials

  11. rocbrutinib

    NMPA: clinical trials

  12. ropivacaine

    NMPA: clinical trials

  13. rotateq

    NMPA: clinical trials

Frequently asked questions

How many drugs start with R?

157 published drug profiles in our index begin with "R".

How do I find a drug by brand name?

Use the search box on the main drugs directory — it matches INN, slug, and therapeutic class. Brand names appear on each drug profile row.